Venus Minerva B. Literal

• A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Patients With Estrogen Receptor Positive, Her2-Negative Early Breast Cancer

• A Registry To Collect Characteristics And Outcomes From Patients With Solid Tumors Profiled With A Next-Generation Sequencing Test (Wayfind-R)

• Phase III, Randomised, Double-blind, Placebo-controlled Study of Durvalumab plus Domvanalimab in Participants with Locally Advanced, Unresectable Non-small Cell Lung Cancer Whose Disease has not Progressed Following Definitive Platinum-based Concurrent Chemoradiation Therapy (PACIFIC-8)

• A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Locally Recurrent Inoperable or Metastatic Breast Cancer (KEYNOTE-B49)
• Study closed

• Similar efficacy, safety, and immunogenicity of FYB206 in comparison to Keytruda as add-on to chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC) -LOTUS Study
• Formycon ended the Lotus trial early after FDA confirmed Phase I data was sufficient—no further testing needed

• Phase III Study to Evaluate the Efficacy and safety of Tezepelumab in Adults with severe uncontrolled asthma (Direction)
• Study closed
• Lung Center of the Philippines

• Immunological Models For Medically Useful Novel Entities (Immune)
• Facilitated ethics submissions for multi-phase studies, including TB-HIV research at LCP
• Managed administrative tasks and prepared budget documents for salary and institutional payments
• Prepared procurement in compliance with government bidding protocols; sourced suppliers for medical and lab equipment
• Supported initial setup of biobanking infrastructure to meet study objectives
• Prepared financial reports and monitored disbursements for a ₱70M grant, achieving 80% Year 1 budget utilization
• Coordinated with funding agencies on timelines, ethics approvals, and procurement milestones

• Clinical Proteomics for Cancer Initiative: Proteomics-based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines (CPCI Study)
• Processed payments for medical charges and institutional fees across multiple partner hospitals
• Coordinated with key institutions during study expansion to support patient recruitment, including: ▸ National Kidney and Transplant Institute (NKTI) ▸ East Avenue Medical Center (EAMC) ▸Jose R. Reyes Memorial Medical Center (JRRMMC) ▸ Rizal Medical Center (RMC)
• Upon study closure, prepared terminal financial reports and facilitated the return of unutilized budget to the funding agency in compliance with grant protocols

Clinical Proteomics for Cancer Initiative: Proteomics-based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines (CPCI Study)

• Monitored project finances and submitted timely financial reports
• Assisted investigators in budget preparation for new study proposals
• Managed administrative processes: salaries, fees, reimbursements, and interdepartmental coordination
• Optimized budget use and prepared budget realignments to support study objectives
• Monitored the ₱30.7M in grants, ensuring regulatory and institutional compliance

Key Responsibilities:

• Conduct market research to identify high-demand health products (e.g., supplements, medical accessories)
• Source and evaluate suppliers both locally and internationally
• Perform detailed product costing and pricing analysis
• Collaborate with the regulatory team to ensure compliance with health standards
• Prepare and deliver strategic product presentations to the company president

• Conduct and approve quality checks at the start of each shift and after any production stoppage to ensure product integrity
• Coordinate with planning, logistics, maintenance, and QA teams for seamless operations
• Respond promptly to production changes and assist in troubleshooting to minimize downtime
• Contribute to process improvements and operational efficiency across daily plant activities